Aktieanalys

Amniotics Q3 2023: Rights Issue Foundation for Lung Transplantation Study - Redeye

{newsItem.title}

Redeye Publicerad: 28 Nov 2023 07:17

Redeye comments on Amniotics' Q3 report, including the rights issue and latest development with the main candidate PulmoStem.

Länk till analysen i sin helhet: https://www.redeye.se/research/963728/amniotics-q3-2023-rights-issue-foundation-for-lung-transplantation-study?utm_source=finwire&utm_medium=RSS

Nyheter om Amniotics

Läses av andra just nu

Om aktien Amniotics

Senaste nytt